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Abstract Dementia is defined as chronic deterioration of
intellectual function and cognitive skills significant
enough to interfere with the ability to perform daily ac-
tivities. Recent advances in the treatment of dementia
have renewed interest in the use of various neuroimaging
techniques that can assist in the diagnosis and differenti-
ation of various subtypes. Neuroimaging and computa-
tional techniques have helped the radiological community
to monitor disease progression of various neurodegenera-
tive conditions presenting with dementia, such as
Alzheimer disease, frontotemporal lobe dementia (FTLD),
progressive supranuclear palsy (PSP) and multisystem
atrophy-cerebellar variant (MSA-C), and their response
to newer therapies. Prompt identification of treatable or
reversible forms of dementia, such as tumours, subdural
haemorrhage and intracranial dAVF, is crucial for the
effective management of these conditions. It is also pru-
dent to recognize the imaging spectrum of metabolic,
infective and autoimmune diseases with rapidly
progressing dementia, such as methanol toxicity, central
pontine myelinolysis (CPM), delayed post hypoxic
leukoencephalopathy (DPHL), HIV, Creutzfeldt-Jakob Dis-
ease (CJD), Sjogren's syndrome, multiple sclerosis (MS),
radiation necrosis and Fragile X-Associated Tremor/Ataxia
Syndrome (FXTAS), which are difficult to treat and often
require palliative care. This pictorial review emphasizes
various non-Alzheimer’s dementia entities and discusses
their imaging highlights.
Teaching Points
• Non Alzheimer’s dementia constitutes a broad spectrum of
conditions.
• Neuroimaging plays an important role in differentiating
treatable from irreversible dementia.
• Neuroimaging is often non-specific in early stages of neu-
rodegenerative conditions with dementia.
• Neuroimaging plays an important role in the multimodal
approach towards management of dementia.
Keywords Dementia . Alzheimer . Atrophy .Myelinolysis .
Ataxia
Introduction
Dementia is a disorder characterized by global impairment in
cognition, social and occupational functioning severe enough
to interfere with daily functioning and quality of life. Various
studies have confirmed an exponential increase in dementia
with age and a higher prevalence in older females [1]. Overall,
dementia has a significant burdening impact onsocio-
economic status and the health care system.
Alzheimer disease (AD) is the most common cause of pri-
mary dementia, constituting 60 % of all cases. Vascular de-
mentia is the second most common form of dementia, which
often coexists with AD. There are various other non-
Alzheimer conditions, which may present with cognitive im-
pairments and can be divided into the broad categories of
neurodegenerative, inflammatory/infective, metabolic/
genetic and miscellaneous. This pictorial review emphasizes
the role of neuroimaging in evaluating various causes of non-
Alzheimer’s dementia. We also highlight conditions with re-
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Vascular dementia (VaD)
Binswanger and Alzheimer first described VaD and recog-
nized the role of multiple infarctions and chronic ischemia in
its etiopathogenesis. VaD is the most common cause of non-
Alzheimer dementia in the aging population and often con-
tributes to cognitive impairment in AD and other forms of so-
called Bmixed dementias^ [2]. Unlike AD, there are no path-
ological criteria for the diagnosis of VaD. The clinical criteria
are poorly understood and validated. It’s a heterogeneous syn-
drome rather than a distinct disorder, in which the underlying
cause is cerebrovascular disease in some form and its ultimate
manifestation is dementia [3]. Three common forms of ische-
mic lesions can result in VaD: 1) Large artery infarcts involv-
ing the cortex and subcortical regions due to thromboembolic
occlusion of major intracranial arteries; 2) Small artery infarc-
tions or lacunes attributed to arteriolosclerosis involving the
penetrating arteries and affecting the thalamus, basal ganglia,
internal capsule, brain stem and cerebellum; 3) Periventricular
white matter disease resulting from chronic subcortical ische-
mia of small arteries affecting the neurons, oligodedrocytes
and astrocytes. Multiple studies have shown that in nearly 6
to 32 % of cases with lobar and lacunar ischemic stroke, one
can show post stroke cognitive impairment and dementia [4].
The presence of microbleeds, a manifestation of small vessel
disease, is also associated with cognitive decline. The number
of infarcts and anatomic distribution of ischemic stroke, rather
than the volume, determines the development of VaD. The
more vulnerable areas are the hippocampus, angular gyrus,
cingulate gyrus, frontal lobe or deep gray and white matter
(thalamus, fornix, basal forebrain, caudate, globus pallidus,
and the genu or anterior limb of the internal capsule) [5].
Advanced age, increased severity of the stroke, recurrent
strokes, white matter disease, cortical atrophy (particularly in
the temporal lobe), hypertension, obesity, elevated homocys-
teine, hyperlipidemia, and diabetes mellitus are the common
associated risk factors [6]. The clinical presentation varies
depending on cortical or subcortical ischemic lesions. Cortical
lesions tend to be sudden onset with more focal neurodeficits,
whereas subcortical lacunar infarcts and white matter disease
have more gradual or stepwise decline of cognitive functions.
The diagnostic approach to patients with suspected VaD is
similar to that of any other form of cognitive decline. Neuro-
imaging should be performed where there is history of stroke,
vascular risk factors and clinical features atypical of AD.Mag-
netic resonance imaging (MRI) is considerably superior in
sensitivity and specificity in detecting ischemic lesions com-
pared to computed tomography (CT); however, radiological
criteria are not adequate enough in differentiating between
post-stroke patients with and without dementia [7]. Microan-
giopathic disease is the condition most commonly associated
with vascular dementia and has non-specific imaging features.
Confluent hypodensities in the periventricular and subcortical
white matter (Fig. 1) with presence of cortical and lacunar
infarcts are seen on CT. Likewise, MRI demonstrates conflu-
ent signal changes in the periventricular and subcortical white
matter, deep grey nuclei and brain stem (Fig. 1). Increasing
white matter lesion burden on serial MRI scans has been as-
sociated with accelerated cognitive decline in several studies
[8]. Acute infarcts typically demonstrate T2W/FLAIR
hyperintensity with diffusion restriction, whereas chronic in-
farcts exhibit volume loss with facilitated diffusion. GRE/SWI
(Gradient Echo/Susceptibility Weighted Imaging) images are
very sensitive in detecting microhaemorrhages noted in mi-
croangiopathic disease and other vascular conditions such as
CADASIL (Cerebral Autosomal Dominant Arteriopathy with
Subcortical Infarcts and Leukoencephalopathy), central ner-
vous system (CNS) vasculitis and amyloid angiopathy. In
summary, there are no uniform diagnostic criteria; however,
a combination of clinical and neuropsychological assessment
with neuroimaging inputs may help in the diagnosis and man-
agement of patients with VaD.
Fig. 1 Vascular dementia. An 86-year-old man with multiple transient
ischemic attacks (TIAs), ongoing changes in level of consciousness and
memory. a & b noncontrast CT scan of the head shows multiple patchy
confluent hypodensities in bilateral basal ganglia (white arrow),
periventricular and subcortical white matter (dashed white arrow). c &
d T2W MRI images of the brain revealing diffuse patchy and confluent
hyperintensities in bilateral basal ganglia (black arrows) and white matter
(dashed black arrow)
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Related conditions
CADASIL
CADASIL is an inherited vasculopathy with subcortical de-
mentia of Binswanger type. It affects the younger population,
beginning in the fourth to fifth decade, and commonly pre-
sents with recurrent transient ischemic attacks, strokes, mi-
graine and cognitive decline [9]. The etiopathogenesis is char-
acteristic vasculopathy of small and medium size arteries.
MRI is the most useful neuroimaging technique to demon-
strate radiological picture of CADASIL. Symmetric and con-
fluent T2W/FLAIR hyperintensities in periventricular and
subcortical white matter are commonly demonstrated in
CADASIL. Anterior temporal lobe white matter involvement
is noted in nearly 90 % of cases and uncommon in other
microvascular diseases. Corpus callosum and insular T2W
hyperintensities are also characteristic findings. DWI and
GRE/SWI sequences are basically helpful in demonstrating
occasional areas of associated acute infarcts and
microhaemorrhages (Fig. 2) [10]. Brain atrophy is another
important feature of CADASIL, likely resulting from subcor-
tical ischemia and strongly correlated with cognitive decline.
Chronic subdural hematoma (SDH)
Chronic SDH is the most frequent cause of traumatic intracra-
nial bleeding in the elderly population, especially in the back-
ground of cerebral atrophy. The mechanism of dementia can
be explained by direct brain compression, reduction in whole
brain cerebral blood flow (CBF) and generalized astrocyte
reactivity. Approximately 45 % of patients with chronic
SDH can have amnesia and cognitive deficits. This is consid-
ered to be one of the treatable forms of dementia and revers-
ible upon surgical evacuation. On CT, chronic SDH often
appears as a hypodense concavo-convex collection. On
T1W and FLAIR MRI, it appears minimally hyperintense in
comparison to CSF due to low paramagnetic methemoglobin
and high protein content (Fig. 3). Membranes with loculations
and varying stages of blood products should raise the suspi-
cion of recurrent haemorrhage [11].
Neurodegenerative
Dementia with Lewy bodies (DLB)
Dementia with Lewy bodies (DLB) is considered as the sec-
ond most common type of degenerative dementia after
Alzheimer disease (AD). Cognitive dysfunction is the fre-
quent initial presentation of DLB, with dementia eventually
occurring in all cases. Unlike Alzheimer disease (AD), the
patients with DLB often present with early impairments in
attention, executive and visuospatial function, with memory
affected later in the course of the disease [12]. Other clinical
manifestations are visual hallucinations, dysautonomia, par-
kinsonism, sleep disorders, and neuroleptic sensitivity. Radio-
logic features are not specific, but may be supportive in the
diagnosis of DLB. Generalized brain atrophy may be noticed
Fig. 2 CADASIL. A 51-year-old
female with left hand weakness,
slurred speech and dysarthria with
progressive cognitive decline. a
& b axial FLAIR and T2W
images of brain demonstrate
patchy confluent hyperintensities
in periventricular (white dashed
arrows) and subcortical white
matter with typical involvement
of temporal lobes (white arrow). c
axial GRE image shows presence
of microhaemorrhage in the
subcortical white matter (black
dotted arrow). d & e axial DWI
and ADC map of brain reveal
focal area of restriction of
diffusion (white arrow head) in
the right corona radiata,
suggesting acute infarct
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on MRI, similar to other neurodegenerative dementia. Few
studies have shown atrophy of the putamen and dorsal
mesopontine gray matter in DLB compared with AD on vol-
umetric MRI scans [13]. As per one study, there can be re-
duced fractional anisotropy in the parieto-occipital white mat-
ter tracts on diffusion tensor imaging in DLB, but not in AD
[14]. Single-photon emission computed tomography (SPECT)
and positron emission tomography (PET) scans may show
decreased perfusion and metabolism in the occipital areas
[15]. The common differential diagnoses for DLB are
Alzheimer disease (AD), Parkinson disease (PD), vascular
dementia, other neurodegenerative dementias, and certain
psychiatric disease. The diagnosis of DLB is primarily based
on the clinical presentations, with radiologic features serving
as helpful tool.
Dementia in Parkinson disease (PD)
Dementia is common and typically appears late in Parkinson
disease (PD). Milder cognitive impairment represented by ex-
ecutive dysfunction and impaired visuospatial function is usu-
ally noted early in the disease [16]. Other associated clinical
features are visual hallucinations, bradykinesia, rigidity and
resting tremor. There are no specific imaging features for
Parkinson disease with dementia; however, one of the recent
neuroimaging studies has described the high accuracy of di-
agnosing PD by demonstrating absence of normal
hyperintensity in the nigrosome-1 of the dorsolateral
substantia nigra (Swallow Tail sign) on SusceptibilityWeight-
ed Imaging (SWI) MR sequence [17]. The most common
differential diagnosis is Dementia with Lewy bodies (DLB).
In PD, dementia generally occurs in the setting of well-
established parkinsonism, whereas in DLB, dementia usually
appears along with or before the development of parkinsonian
signs. Quantitative morphometric MRI study can help in dif-
ferentiating both entities with evidence of more pronounced
cortical atrophy in DLB compared to PD. [18] Other differen-
tial diagnoses include progressive supranuclear palsy (PSP),
corticobasal degeneration, Alzheimer disease and vascular
dementia.
Multiple system atrophy- cerebellar type (MSA-C)
MSA-C was formerly called olivopontocerebellar degenera-
tion, with onset at a mean age of 56 to 60 years. It is a sporadic
disease with a combination of Parkinsonism symptoms, auto-
nomic failure and cerebellar ataxia. Dementia is uncommon
and of the frontal type, but is found in a minority of patients
[19]. There is neuronal cell loss and gliosis in inferior olivary
and pontine nuclei, cerebellar hemispheres and vermis. Com-
mon MR imaging features are selective atrophy of pons, mid-
dle cerebellar peduncles, cerebellar hemispheres and inferior
olives (Fig. 4). An abnormal hyperintense signal that results
from the degeneration of the transverse pontine fibres and
pontine raphe gives the appearance of a BHot Cross Bun^ sign
on T2W/FLAIR images (Fig. 4b) [20]. Although a non-
specific finding, it has also been observed in variant
Creutzfeldt-Jakob disease, spinocerebellar atrophy types 2
and 3 and in parkinsonism secondary to vasculitis.
Progressive supranuclear palsy (PSP)
PSP is the most common form of atypical parkinsonian disor-
der, which can present with early executive dysfunction or
subcortical dementia and clinically presents with supranuclear
gaze palsy and motor symptoms. [21] Like FTLD, PSP is also
related to abnormal tau protein deposition. Midbrain and su-
perior cerebellar peduncle atrophy are classic neuroimaging
features. Loss of normal superior midbrain tegmentum con-
vexity with a relatively preserved pons on T1W mid-sagittal
images gives the Bhummingbird or penguin^ beak appearance
(Fig. 5a). Atrophy of superior cerebellar peduncles strongly
Fig. 3 Chronic subdural hematoma (SDH). A 73-year-old male with
trivial head trauma later developed progressive loss of cognitive function.
a & b axial T2W and FLAIR sections of brain show hyperintense extra
axial fluid collection in bilateral cerebral convexities (white arrows) with
severe compression of adjacent cerebral hemispheres and effacement of
the ventricles & sulci. c axial GRE image of the brain demonstrate pre-
dominantly hyperintense fluid in bilateral cerebral convexities with
hypointense margin on the medial aspect. There are also localized
hypointensities (blooming susceptibility artefacts from the blood prod-
ucts) on the anterior aspects of the collections (black arrows)
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correlates with disease duration. Reduced anteroposterior
midbrain diameter at the level of superior colliculus gives
the BMickey Mouse^ appearance on axial images (Fig. 5c)
[22]. Axial images may also show abnormal concavity of
the lateral tegmental margin, giving the impression of a
Bmorning glory^ flower (Fig. 5b) [23]. A number of studies
have used quantitative measurements to establish the specific-
ity of atrophy pattern noted in PSP, and tried to differentiate
from idiopathic parkinson's disease or MSA-P [24]. The
anterior-posterior diameter and average area of the midbrain
were found to be significantly lower in patients with PSP
(56 mm2) compared to idiopathic Parkinson disease
(103 mm2) or multiple system atrophy-parkinsonism (MSA-
P) (97 mm2) [25]. Similarly, PSP has shown a significantly
higher ratio of the mid-sagittal pons to midbrain area com-
pared with matched controls, multiple system atrophy or
Parkinson disease. Few studies have suggested that magnetic
resonance-parkinsonism index (MRPI) can be used to distin-
guish PSP from Parkinson disease and atypical parkinsonian
syndrome [26]. It is an index calculated from the formula
(P/M) × (MCP/SCP), which requires measurement of the area
of the pons (P) and midbrain (M) and width of the middle
cerebellar peduncle (MCP) on sagittal T1-weighted MRI and
the width of the superior cerebellar peduncle (SCP) on coronal
MRI.
Frontotemporal lobar dementia (FTLD)
FTLD is a group of neurodegenerative diseases with a rela-
tively rarer form of rapidly progressive dementia, characteris-
tically involving the fronto-temporal lobes and insula. Clini-
cally it comprises three subtypes: behavioral variant
frontotemporal dementia (bvFTD), semantic dementia (SD)
and nonfluent aphasia. The bvFTD is characterized bymarked
personality changes and behavioural problems, the most ag-
gressive subtype with earliest average age of onset (fifth to
sixth decade) and male preponderance [27]. SD or the tempo-
ral variant is also known as the least aggressive variant, and
typically presents with either word finding difficulty or
prosopagnosia (inability to recognize faces), depending on
Fig. 5 Progressive Supranuclear Palsy (PSP). A 79-year-old male with
gait ataxia and frequent falls with forgetfulness and loss of interest in
routine activity. a sagittal T1W image of the brain shows loss of superior
convexity of midbrain: BHumming bird or penguin sign^ (white dashed
arrow). b axial T1W section of the brain at the level of midbrain reveals
abnormal concavity of lateral margin of midbrain: Bmorning glory sign^
(white arrows). c axial FLAIR imaging of brain is demonstrating de-
creased anteroposterior diameter of midbrain (white dashed arrow)
Fig. 4 Multisystem atrophy-cerebellar variant (MSA-C). A 79-year-old
female with a two-year history of urinary incontinence, ataxia, rigidity,
generalized atrophy and cognitive decline. a axial T2 W section of the
posterior fossa shows atrophy of bilateral brachium pontis with hyperin-
tense signal changes (white arrows). b axial T2W image at the level of
pons demonstrates typical hot cross bun sign (white circle) and significant
atrophy and T2W hyperintensity in bilateral cerebellar hemispheres
(white dashed arrows). cmidline sagittal T2W image of brain is showing
atrophy of pons mostly on the anterior aspect (short white arrow)
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the predominant temporal lobe predilection [28]. Patients with
non-fluent aphasia generally present with speech apraxia [29].
The characteristic neuropathological finding in FTLD is tau
proteinopathy, as in AD. Neuroimaging is non-specific in the
early phase of disease with overlap among subtypes, and is
used primarily to exclude other forms of dementia. With clin-
ical progression, FTLD subtypes frequently show specific pat-
terns of focal cortical atrophy with the classic Bknife edge^
appearance involving frontal and/or temporal lobes. In the
bvFTD subtype, bifrontal atrophy is the most common find-
ing, which usually progresses to involve the temporal lobes at
a later stage of the disease [30]. Behavioural changes are usu-
ally attributed to predominant involvement of the right frontal
lobe (Fig. 6). The SD variant has predominant anterior tem-
poral lobe atrophy and is more frequently marked on the left
side, unlike AD, in which the temporal lobe involvement
tends to be symmetric with no antero-posterior gradient.
Prominent atrophy of the left perisylvian region is character-
istic of non-fluent aphasia [31]. Additionally, molecular imag-
ing with either FDG-PET or rCBF (relative Cerebral Blood
Flow) SPECT and quantitative analysis using 3D T1 MRI
have shown good specificity in differentiating FTLD and
AD based on identification of asymmetric and predominantly
anterior versus posterior pattern of hypometabolism/perfusion
and atrophy.
Huntington’s disease (HD)
HD is an autosomal dominant, inherited progressive
neurodegenerative disorder caused by a trinucleotide
(CAG) repeat expansion in the huntingtin gene. It is
characterized by abnormal choreiform movements, psy-
chiatric symptoms and early onset dementia [32]. Cog-
nitive deficits are inevitable in HD and common clinical
manifestations are executive dysfunction, lack of insight
and slowed processing. Caudate atrophy is the typical
neuroimaging finding on axial MRI images (Fig. 7), and
changes in linear caudate measurements correlate with
severity of cognitive dysfunction [33]. Abnormal meta-
bolic changes can also be noted on positron-emission
tomography (PET) and functional MRI [34]. The differ-
ential diagnosis of HD is broad and ranges from benign
familial chorea to hereditary and acquired neurodegen-
erative diseases. The diagnosis of HD is principally
based upon a combination of clinical features, family
history and presence of trinucleotide (CAG) repeat ex-
pansion in the HTT gene.
Inflammatory/Infective
Creutzfeldt-Jakob disease (CJD)
CJD is a fatal prion disease causing rapidly progressive de-
mentia due to sub-acute spongiform encephalopathy. It com-
monly presents in the fifth to seventh decade of life with a
triad of subacute dementia, myoclonus and characteristic
triphasic EEG pattern. Elevated tau and/or 14-3-3 protein is
seen on CSF analysis. MRI is the most suitable neuroimaging
technique in the diagnosis of CJD, with T2W, FLAIR and
DWI sequences being the most essential sequences of the
MRI protocol. The key MRI features in CJD are T2W/
FLAIR hyperintensity in the caudate, putamen, anterior cin-
gulate gyrus and thalamus. Widespread involvement of the
cerebral cortex is also a characteristic feature [35]. DWI is
very sensitive and shows diffusion restriction, especially in
early stage of the disease, with no visible changes on T2W/
FLAIR sequences (Fig. 8) [36]. Generalized atrophy is usually
noted in late or terminal CJD. Variant CJD (vCJD) commonly
presents with psychiatric symptoms and selective T2W/
FLAIR hyperintensity with diffusion restriction in the medial
and dorsal thalami (pulvinar), giving the appearance of
Bhockey-stick^ or Bpulvinar sign^ [37]. A combination of
clinical, neuroimaging and neuropathological findings fre-
quently leads to the definitive diagnosis of CJD.
Fig. 6 Behavioural variant Frontotemporal dementia (bvFTD). A 53-
year-old male with progressive personality change and behavioural prob-
lems with cognitive decline. a, b & c axial CT sections of brain show
severe right frontal lobe atrophy (white arrow), as well as some atrophy of
right anterior temporal lobe (black arrow)
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HIV-Associated dementia (HAD)
Human Immunodeficiency Virus (HIV-1) has created a global
crisis, with approximately 50 million people infected world-
wide. HAD has also been previously referred to as AIDS
dementia complex, HIV encephalitis or encephalopathy, and
is seen in approximately 25–52 % of patients with HIV infec-
tion, depending on disease state and anti-retroviral therapy.
Patients develop insidious onset intellectual disturbance, psy-
chomotor slowing and memory impairment. Generalized
brain atrophy is the most common imaging finding. MRI
may show patchy T2W/FLAIR hyperintensities in
periventricular and subcortical white matter, which tends to
be more diffuse and confluent with disease progression
(Fig. 9) [38]. Lack of brain parenchymal or meningeal en-
hancement differentiates it from other opportunistic infec-
tions. Bilateral symmetrical hyperintensity in basal ganglia,
thalami and brainstem has been described in the literature
[39]. Advanced imaging techniques like magnetization trans-
fer (MT) and proton MR spectroscopy (MRS) have shown
low MT and decreased glutamate, NAA/choline ratios with
increased myoinositol in the affected brain regions [39].
Sjogren’s syndrome (SS)
Sjogren’s syndrome is one of the most common autoim-
mune diseases, affecting the exocrine glands and manifest-
ing as sicca syndrome. CNS involvement is noted in ap-
proximately 20 % of patients, presenting with transverse
myelitis and aseptic meningitis. It can manifest as steroid-
responsive treatable dementia, which is caused by angiitis
or nonvasculitic autoimmune inflammatory meningoen-
cephalitis (NAIM). Cognitive and behavioural disorders
like forgetfulness and bradyphrenia are some known pre-
sentations. MR imaging can often be normal or show non-
specific perivascular and subcortical small punctate white
matter lesions (Fig. 10) [40, 41].
Fig. 7 Huntington’s disease. A 62-year-old male presented with abnor-
mal choreiform movement of the limbs, psychiatric manifestations and
dementia. a axial T2W image at the level of lateral ventricles is showing
significant atrophy of bilateral caudate nuclei (black arrows) and frontal
lobes. b corresponding axial FLAIR image also demonstrates significant
caudate atrophy (white arrows) and enlargement of frontal horns
Fig. 8 Creutzfeldt-Jakob Disease
(CJD). a FLAIR axial image of
the brain shows hyperintensity in
the right caudate head, putamen
(white arrow) and occipital cortex
(white dashed arrow). b & c
diffusion weighted image and
ADC map reveal restriction of
diffusion in the right caudate
head, putamen and occipital
cortex. d & e diffusion weighted
image and ADC map at higher
level demonstrate restriction of
diffusion in the right
frontoparietal cortex
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Multiple sclerosis (MS)
MS is a demyelinating disease involving both white and gray
matter. Focal neurological deficits caused by lesions in an
eloquent long tract, like optic neuritis or a spinal cord
syndrome, are common presentations. Nearly one in 20
patients can manifest with dementia and the common im-
aging finding is nonspecific generalized atrophy (Fig. 11)
[42]. The degree of cognitive decline is proportional to the
disease burden on MRI. Abnormal Magnetization Transfer
Ratio (MTR) or Fractional Anisotropy (FA) have been
reported in the cortex of MS patients with reduced NAA
and increased mI/Cr (mI- myo inositol, Cr- Creatine) ratios
in deep grey matter on MRS, suggesting both axonal in-
jury and gliosis [42].
Metabolic/Genetic
Delayed post hypoxic leukoencephalopathy (DPHL)
There are three basic mechanisms of developing hypoxic-
ischemic brain injury- hypovolemia (cardiac failure), hypo-
oxygenation (respiratory failure) and impaired oxygenation
(CO poisoning) [43]. Initial clinical presentation includes a
brief period of coma or altered consciousness. Recovery
Fig. 10 Sjogren’s syndrome. A 71-year-old female presented to hospital
with unsteadiness, frequent falls and dementia with features of Sjogren’s
syndrome. a & b axial T2W and FLAIR images of the brain show non-
specific patchy confluent hyperintensities in bilateral periventricular
white matter
Fig. 9 HIV-Associated Dementia (HAD). A 56-year-old female with a
several-month history of generalized weakness, confusion and memory
loss. a & b axial T2W and FLAIR images of the brain at the level of
ventricles show diffuse symmetrical white matter hyperintensity and mild
generalized atrophy. c & d axial T2W and FLAIR images at the level of
centrum semiovale reveal similar diffuse symmetrical hyperintensity in
the white matter
Fig. 11 Mutliple Sclerosis (MS). A 40-year-old female with history of
relapsing remitting multiple sclerosis (RRMS) for the last 5 years, recent-
ly developed progressive memory decline. a axial FLAIR image of the
posterior fossa shows a hyperintense demyelinating lesion in the right
brachium pontis (white dashed arrow). b, c & d axial FLAIR and T2W
images at the level of lateral ventricles demonstrate multiple hyperintense
lesions in periventricular white matter (white arrows) and generalized
atrophy
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from the initial insult can manifest with short-term mem-
ory loss, confusion, ataxia and poor performance in exec-
utive function. Delayed post-hypoxic demyelination is con-
sidered to be the cause for cognitive deficits [44]. Diffuse
cortical, periventricular white matter and deep gray matter
T2W/FLAIR hyperintensity with DWI restriction are fre-
quently noted on MRI (Fig. 12) [44]. The imaging appear-
ance may overlap in few other conditions such as PRESS,
spongiform leukoencephalopathy secondary to inhaled her-
oin and metachromatic leukodystrophy; however, history
of hypoxia and cognitive decline are helpful in differenti-
ating DPHL from other conditions.
Acute methanol toxicity
Methanol is a highly toxic, colourless liquid that resembles
ethanol in taste and smell. Intoxication is common after
suicidal or accidental ingestion and fraudulent adulteration
of alcoholic beverages. It results in severe metabolic aci-
dosis and optic necrosis or demyelination leading to vision
loss. Severe toxicity may progress to Parkinson-like
extrapyramidal syndrome, cognitive deficits/dementia, per-
manent neurological deficits and death [45]. Both CT and
MRI are helpful in demonstrating the changes in the brain.
Bilateral putaminal necrosis with varying degrees of haem-
orrhage is the crucial imaging feature (Fig. 13). Cerebral
and intraventricular haemorrhage, cerebellar and subcorti-
cal white matter necrosis and diffuse cerebral oedema are
other common imaging manifestations [46]. Imaging dif-
ferential diagnosis could include carbon monoxide poison-
ing, stroke, Wilson and Leigh disease.
Central pontine myelinolysis
Central pontine myelinolysis is an acute demyelinating pro-
cess affecting the central pontine fibres and frequently associ-
ated with chronic alcoholism, nutritional deficiency and rapid
correction of hyponatremia (osmotic demyelination). Spastic
quadriparesis, pseudobulbar palsy, altered level of conscious-
ness and coma are usual presentations. Dementia component
and behavioural changes are likely from callosal involvement
Fig. 12 Delayed Post Hypoxic Leukoencephalopathy (DPHL). A 42-
year-old male prisoner with history of substance abuse presented with
altered level of consciousness, confusion, ataxia andmemory loss. a axial
FLAIR image is showing symmetrical necrosis of bilateral globus
pallidus (black arrows). b axial FLAIR image at the level of ventricles
demonstrates symmetrical periventricular and deep white matter
hyperintensity (white arrow). c & d diffusion weighted image and ADC
map reveal symmetrical restriction of diffusion in the deep white matter
Fig. 13 Methanol toxicity. A 52-year-old female with a history of acci-
dental methanol ingestion, presented with cognitive decline and rigidity
in the extremities. a & b axial T2Wand FLAIR images of the brain show
necrosis of bilateral putamen (black arrows) and head of caudate nuclei
(white arrow)
Fig. 14 Central Pontine Myelinolysis (CPM). A 61-year-old male with
history of ETOH abuse with decrease in function, poor balance and de-
mentia. a & b axial T2W and FLAIR images at the level of pons show
central pontine hyperintensity (black arrow)
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[47]. Symmetric ‘Trident shaped’ T2W/FLAIR hyperintensity
in the central pons with sparing of corticospinal tract are char-
acteristic MR imaging features (Fig. 14). Diffusion restriction
may be seen in the early phase with occasional peripheral post
contrast enhancement [48]. Stroke, MS, encephalitis, glioma
and toxic encephalopathy are common MR imaging differen-
tial diagnoses.
Fragile X-associated tremor/Ataxia syndrome (FXTAS)
FXTAS is a late onset X linked genetic cause of mental
retardation and autism due to trinucleotide repeat mutation
of the Fragile X Mental Retardation 1 (FMR1) gene, and
is commonly seen in males between the ages of 50 and80
years. The clinical presentation includes intentional tremor,
ataxia, neuropathy, and personality changes in association
with memory loss. Atrophy of the cerebral and cerebellar
hemispheres, middle cerebellar peduncles, pons, medulla
and corpus callosum are the important imaging features.
Symmetric T2W/FLAIR hyperintense lesions in the cere-
bellar hemispheres close to the dentate nucleus, pons and
bilateral middle cerebellar peduncles (MCP sign) are com-
monly noted (Fig. 15a & b). In addition, symmetric
patchy and/or confluent hyperintensities can be seen in
periventricular and deep white matter of cerebral hemi-
spheres with sparing of subcortical U fibers, cortical and
deep gray matter and corpus callosum (Fig. 15c) [49].
Miscellaneous
Intracranial dural AV fistula (dAVF)
dAVF is an acquired pathological shunt between intracranial
arteries and dural venous sinuses, meningeal or cortical veins.
Fig. 16 Intracranial dural AV fistula. A 69-year-old male with a 1-month
history of progressive cognitive decline. a & b axial T2W and GRE
images of the brain show prominent superior sagittal sinus (black
arrow) with multiple tortuous superficial cortical (arrow head) and
medullary veins (white arrow). c right external carotid artery injection
reveals dural AV fistula with abnormal communication between supe-
rior sagittal sinus (black arrow) and arterial feeders from right middle
meningeal artery (dashed black arrow) and transosseous branches of
right superficial temporal artery (short black arrow). d Late venous
phase of the catheter angiogram shows prominent medullary venous
drainage giving the appearance of pseudophlebitic appearance (dashed
white arrows)
Fig. 15 Fragile X- Associated Tremor/Ataxia Syndrome (FXTAS). A
61-year-old male presented with a two-year history of tremor, rigidity in
all four limbs, paresthesia with recent memory decline. a axial T2W
image of the posterior fossa show atrophy and T2W hyperintensity in
bilateral cerebellar hemisphere (white arrows). b axial T2W section of
the brain at the level of pons demonstrate symmetrical hyperintensity in
pons (dashed white arrow) and hyperintensity in bilateral middle cerebel-
lar peduncles (black arrows). c axial T2W image of the brain at the level
of lateral ventricles is revealing significant atrophy and T2W
hyperintensities in bilateral cerebral hemispheres
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It mostly presents in the fifth or sixth decades and the common
locations are in transverse, sigmoid and cavernous sinuses
[50]. Many dAVFs remain asymptomatic or have a benign
course, but can present with cranial neuropathy, seizures, par-
kinsonism, cerebellar symptoms and intracranial haemorrhage
in higher grade dAVFs. Cognitive decline and global dementia
are uncommon clinical manifestations most likely resulting
from venous hypertension and brain ischemia associated with
impaired venous drainage [51]. Unenhanced CT is particularly
limited to detecting intracranial haemorrhage and brain oede-
ma. MRI is mainly suitable for demonstrating ectatic vessels,
venous pouches, and signs of venous congestion such as white
matter signal changes, haemorrhage, or venous infarcts
(Fig. 16a and b). Dynamic CTA and time resolved MRA can
be useful for demonstrating the dAVF and its relation to sur-
rounding brain and skull, and thus may help in treatment plan-
ning. Digital subtraction angiogram is most accurate in dem-
onstrating cranial dAVF, with superior visualization of arterial
feeders, site of AV shunting and venous drainage (Fig. 16c &
d) [51]. Although a very rare cause of dementia, it can be
reversible upon successful embolization of the fistula.
Normal pressure hydrocephalus (NPH)
Normal pressure hydrocephalus represents ventricular dilata-
tion and clinical triad of cognitive decline, gait disturbance
and urinary incontinence with normal CSF opening pressure.
Management of this condition is a dilemma because of diag-
nostic uncertainty, and requires careful patient selection for
CSF shunting. The aetiology is still debatable and explained
by two existing theories: 1) Impaired CSF absorption due to
prior meningitis or subarachnoid haemorrhage and 2) De-
creased white matter tensile strength due to ischemic changes
[52]. Imaging plays a minor role and MRI findings that may
suggest NPH are 1) disproportionate ventricular dilatation in
comparison to sulcal prominence; 2) periventricular halo sug-
gesting transependymal CSF flow; and 3) prominent CSF
flow void at the aqueduct of Sylvius, attributable to excessive
rapidly pulsatile CSF flow [53]. Ballooning of the corpus
callosum is another imaging feature (Fig. 17). MRI cine flow
velocity mapping measures the aqueductal CSF flow velocity
Fig. 18 Radiation necrosis with dementia. A 52-year-old male with his-
tory of nasopharyngeal carcinoma with radiotherapy developed progres-
sive decline in cognition after 7 years of treatment. a axial post contrast
T1W image at the level of skull base (2003) shows heterogeneously
enhancing right side nasopharyngeal carcinoma (black arrow). b axial
post contrast T1W image of the skull base (2007) reveals complete reso-
lution of the mass lesion (white arrow). c & d axial FLAIR and post
contrast T1W images of the brain at the level of middle cranial fossa
(2010) demonstrate extensive white matter hyperintensity (black arrows)
and heterogeneous enhancement—BSwiss-cheese^ pattern in bilateral
temporal lobes (white arrows)
Fig. 17 Normal Pressure Hydrocephalus (NPH). A 75 -ear-old male
presented with progressive gait ataxia and memory loss. a axial CT sec-
tion of the brain shows dilated lateral ventricles with effaced sulci. b & c
axial T2W images of brain at the level of ventricles demonstrate dilatation
of all the ventricles with prominent CSF flow void in the fourth ventricle
(black arrow). d paramedian sagittal T1W section reveals ballooned cor-
pus callosum with effacement of sulci towards vertex (white arrow)
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and stroke volume is used at some centres to predict the re-
sponse to shunt surgery.
Radiation necrosis
Patients irradiated for nasopharyngeal and oropharyngeal tu-
mours can also present with cognitive and memory impair-
ment due to bilateral temporal lobe involvement [54]. Radia-
tion necrosis is a late complication occurring between
6 months to more than 10 years after radiotherapy. Diffuse
T2/FLAIR hyperintense signal reflecting white matter oede-
ma, cortical thinning and nodular, curvilinear or ring type post
contrast enhancement are the commonMRI features. The typ-
ical radiation necrosis enhancement has been described as a
BSwiss-cheese^ pattern (Fig. 18) [55]. MR perfusion and
SPECT/PET studies may be useful in distinguishing viable
tumour and radiation necrosis with low perfusion/
hypometabolism in the latter [55].
Brain tumours
Both extra and intra axial tumours, when situated near elo-
quent areas, may present with slowly progressing neuropsy-
chological, behavioural disturbance and dementia. It is poten-
tially a reversible cause of dementia if amenable to surgical
resection. Common locations are being middle cranial fossa,
basal frontal regions, thalamus, corpus callosum, cingulate
gyrus and limbic system (Fig. 19). Neuroimaging aids in ex-
cluding tumoral pathologies in unexplained behavioural and
cognitive disturbances [56].
Conclusion
Non-Alzheimer’s dementia comprises several pathologies
varying from rapid onset to gradually progressive disease
spectrum. Often there is considerable clinical overlap, and
neuroimaging features tend to be non-specific during the ini-
tial stage of disease. The rationale of conventional neuroim-
aging is not to offer definitive diagnoses, but to suggest pos-
sible differential diagnoses and track evolving changes on
follow-up studies. Newer molecular imaging bio-markers
combined with conventional neuroimaging techniques hold
promise in assessing applications of novel disease-
modifying drugs for treatment and response evaluation. An
important aspect of neuroimaging is also to recognize revers-
ible or treatable causes of dementia that can potentially be
treated or halt further disease progression.
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